The agreement provides relief to federally funded programs that provide free or low-cost drugs to around 110,000 low-income people nationwide. Other news is on the side effects of antidepressants; the cause of auditory…
Category: 6. Health
-
Among T2D Drugs, GLP-1s Top Others for Reducing CV Events – Medscape
- Among T2D Drugs, GLP-1s Top Others for Reducing CV Events Medscape
- 2 Minute Medicine Rewind October 20, 2025 2 Minute Medicine
- GLP-1 RAs emerge as frontrunner for CV risk protection: JAMA study AusDoc
- Diabetes medications vary in ability to…
Continue Reading
-
During cold and flu season, youngest children are germier than older kids, study says
By AP with Euronews
Published on
Forget colourful leaves. Any caregiver knows that the…
Continue Reading
-
Characteristics of Preoperative Anemia and Its Impact on Perioperative
Introduction
The incidence of preoperative anemia in gynecological inpatients ranges from 24–45%,1,2 diseases like endometrial polyps, gynecological malignancy, uterine leiomyoma and adenomyosis are the common causes. The diagnostic threshold…
Continue Reading
-
New survey paints grim picture of working with Parkinson’s
People with Parkinson’s have the potential to work for longer if given adequate support in the workplace, according to a new study by Parkinson’s Europe.
Lack of knowledge around workplace rights,…
Continue Reading
-
Less Than Half of UK Students at Risk of Food Anaphylaxis Receive Epinephrine
Less than half of schoolkids at risk of food
anaphylaxis in England are prescribed adrenaline autoinjectors (AAIs), a new analysis found. The study also showed that if schools received spare AAIs, this would replace children leaving their own…Continue Reading
-
Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy
Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers at…
Continue Reading
-
Generic Lenacapavir Could Help End HIV Epidemic by 2030 – Medscape
- Generic Lenacapavir Could Help End HIV Epidemic by 2030 Medscape
- IDWeek 2025: Reduced pricing for lenacapavir is possible and profitable European AIDS Treatment Group
- Generic Lenacapavir Could Cost as Little as $25 Per Person Annually Contagion…
Continue Reading
-
Emerging strategies for monkeypox: antigen and antibody applications in diagnostics, vaccines, and treatments | Military Medical Research
Ulaeto D, Agafonov A, Burchfield J, Carter L, Happi C, Jakob R, et al. New nomenclature for mpox (monkeypox) and monkeypox virus clades. Lancet Infect Dis. 2023;23(3):273–5.
Google Scholar
…Continue Reading
-
Exploring the perspectives of young adults on mental healthcare and systemic health, education, and social challenges in Australia: a qualitative study | BMC Health Services Research
Findings
Thematic analysis of focus group and interview discussions revealed complex perceptions of systemic challenges within healthcare, education, and social systems. Participants expressed their frustration and a sense of disconnection,…
Continue Reading